International Clinical Trial: Exploration of the efficacy and safety of IL - 1 inhibitors in the treatment of systemic sclerosis

Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124295) titled 'Exploration of the efficacy and safety of IL - 1 inhibitors in the treatment of systemic sclerosis' on May 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Affiliated Hospital of North Sichuan Medical College

Condition: Systemic sclerosis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-05-24

Target Sample Size: experimental group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=315050

Published by HT Digital Content Services with permission from Health Daily Digest....